• by Philip Rosenfeld, M.D., PhD.
• Medically reviewed by Thomas J. Walsh, M.D.

About Philip Rosenfeld, M.D., PhD.

Dr. Rosenfeld is Professor of Ophthalmology at the world-renowned Bascom Palmer Eye Institute at the University of Miami, Miller School of Medicine. Dr. Rosenfeld’s chief research interests are in the diagnosis, treatment and genetics of macular diseases. He is at the forefront of medical testing having spent the past decade seeking effective therapies for AMD. He is currently Principal Investigator of nine clinical trials for AMD. In May 2005, Dr. Rosenfeld was the first to perform an intravitreal injection of Avastin?a drug approved to treat colon cancer?for the treatment of wet AMD and his findings have since been put into practice by physicians around the world. Dr. Rosenfeld received a Medical Degree and PhD from the Johns Hopkins University School of Medicine in Baltimore.